- Previous Close
0.180 - Open
0.162 - Bid 0.156 x --
- Ask 0.172 x --
- Day's Range
0.162 - 0.169 - 52 Week Range
0.155 - 0.275 - Volume
178,000 - Avg. Volume
33,360 - Market Cap (intraday)
361.207M - Beta (5Y Monthly) -0.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.020 - Earnings Date Mar 28, 2025
- Forward Dividend & Yield 0.00 (1.55%)
- Ex-Dividend Date Jun 13, 2024
- 1y Target Est
--
Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It provides Chinese medicines, chemical drugs, biological and health products, and medical appliances covering therapy areas of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, anti-cancer, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces, and Chinese medicines; provision of Chinese medicine clinical and medical services; and trading of agricultural by-products. In addition, the company provides healthcare services, such as general TCM treatment, health preservation, and health management services, as well as personalized systems for disease diagnosis, treatment, and prevention along with health preservation. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
www.tiandapharma.com701
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 0455.HK
View MorePerformance Overview: 0455.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0455.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0455.HK
View MoreValuation Measures
Market Cap
361.21M
Enterprise Value
362.02M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.94
Price/Book (mrq)
0.66
Enterprise Value/Revenue
0.94
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-18.60%
Return on Assets (ttm)
-4.02%
Return on Equity (ttm)
-11.19%
Revenue (ttm)
329.94M
Net Income Avi to Common (ttm)
-61.37M
Diluted EPS (ttm)
-0.020
Balance Sheet and Cash Flow
Total Cash (mrq)
85.69M
Total Debt/Equity (mrq)
25.20%
Levered Free Cash Flow (ttm)
--